Rate Control in Atrial Fibrillation II
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 122 participants.
Also called NCT02695992
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 122 participants
- Sponsor
- Asker & Baerum Hospital
- Registry
-
NCT02695992 -
2015-001918-98
-
- Other papers using this trial's data
- Effects of diltiazem and metoprolol on levels of high-sensitivity troponin I in patients with permanent atrial fibrillation: a randomized trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Norway
- Registry status
- Completed
Technical summary
Registry record NCT02695992. Randomized; single masking; primary purpose treatment. Start 2016-02 (registry gives no type); primary completion 2021-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Rate Control in Atrial Fibrillation II
- Acronym
- RATAFII
- Condition
- Atrial Fibrillation
- Condition
- Permanent Atrial Fibrillation
- Intervention (Drug)
- Metoprolol
- Intervention (Drug)
- Diltiazem
- Lead sponsor
- Asker & Baerum Hospital
- Collaborator
- Vestre Viken Hospital Trust
- Collaborator
- Helse Sor-Ost
Record details
- Record id
cardio:ct-nct02695992- Content hash
34ccdaf7983f9b125ae368d8bb2fe6d1e1ce1e085a017da47247176304855409